Login to Your Account

Takeda Getting Millennium, Velcade in $8.8B Cash Deal

By Glen Harris

Friday, April 11, 2008
Takeda Pharmaceuticals Ltd. continued its recent love affair with U.S. biologics, entering into an agreement to purchase Millennium Pharmaceuticals Inc. for $8.8 billion, and instantly gaining a strong foothold in the cancer field. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription